These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12230888)

  • 1. Outlier mining in high throughput screening experiments.
    Engels MF; Wouters L; Verbeeck R; Vanhoof G
    J Biomol Screen; 2002 Aug; 7(4):341-51. PubMed ID: 12230888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry tools: making sense of HTS data.
    Kolossov E; Lemon A
    Eur J Med Chem; 2006 Feb; 41(2):166-75. PubMed ID: 16368163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel statistical approach for primary high-throughput screening hit selection.
    Yan SF; Asatryan H; Li J; Zhou Y
    J Chem Inf Model; 2005; 45(6):1784-90. PubMed ID: 16309285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
    Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
    ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic extraction of structure-activity relationship information from biological screening data.
    Wawer M; Bajorath J
    ChemMedChem; 2009 Sep; 4(9):1431-8. PubMed ID: 19621333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of structure-activity relationship pathways in biological screening data.
    Wawer M; Peltason L; Bajorath J
    J Med Chem; 2009 Feb; 52(4):1075-80. PubMed ID: 19140668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the BioAssay Ontology for analyzing high-throughput screening data.
    Zander Balderud L; Murray D; Larsson N; Vempati U; Schürer SC; Bjäreland M; Engkvist O
    J Biomol Screen; 2015 Mar; 20(3):402-15. PubMed ID: 25512330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate Hit Estimation for Iterative Screening Using Venn-ABERS Predictors.
    Buendia R; Kogej T; Engkvist O; Carlsson L; Linusson H; Johansson U; Toccaceli P; Ahlberg E
    J Chem Inf Model; 2019 Mar; 59(3):1230-1237. PubMed ID: 30726080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.
    Marrero-Ponce Y; Meneses-Marcel A; Castillo-Garit JA; Machado-Tugores Y; Escario JA; Barrio AG; Pereira DM; Nogal-Ruiz JJ; Arán VJ; Martínez-Fernández AR; Torrens F; Rotondo R; Ibarra-Velarde F; Alvarado YJ
    Bioorg Med Chem; 2006 Oct; 14(19):6502-24. PubMed ID: 16875830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent hit series hidden in high-throughput screening data.
    Varin T; Didiot MC; Parker CN; Schuffenhauer A
    J Med Chem; 2012 Feb; 55(3):1161-70. PubMed ID: 22185196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning from the data: mining of large high-throughput screening databases.
    Yan SF; King FJ; He Y; Caldwell JS; Zhou Y
    J Chem Inf Model; 2006; 46(6):2381-95. PubMed ID: 17125181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-high-throughput screening analysis: an empirical compound prioritization scheme.
    Oprea TI; Bologa CG; Edwards BS; Prossnitz ER; Sklar LA
    J Biomol Screen; 2005 Aug; 10(5):419-26. PubMed ID: 16093551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B
    Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data.
    Paricharak S; IJzerman AP; Bender A; Nigsch F
    ACS Chem Biol; 2016 May; 11(5):1255-64. PubMed ID: 26878899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical approaches to efficient screening: information-rich screening protocol.
    Karnachi PS; Brown FK
    J Biomol Screen; 2004 Dec; 9(8):678-86. PubMed ID: 15634794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust statistical methods for hit selection in RNA interference high-throughput screening experiments.
    Zhang XD; Yang XC; Chung N; Gates A; Stec E; Kunapuli P; Holder DJ; Ferrer M; Espeseth AS
    Pharmacogenomics; 2006 Apr; 7(3):299-309. PubMed ID: 16610941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the prediction of statistical parameters in high-throughput screening using resampling techniques.
    Ilouga PE; Hesterkamp T
    J Biomol Screen; 2012 Jul; 17(6):705-12. PubMed ID: 22460175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical analysis of systematic errors in high-throughput screening.
    Kevorkov D; Makarenkov V
    J Biomol Screen; 2005 Sep; 10(6):557-67. PubMed ID: 16103415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of biological activity for high-throughput screening using binary kernel discrimination.
    Harper G; Bradshaw J; Gittins JC; Green DV; Leach AR
    J Chem Inf Comput Sci; 2001; 41(5):1295-300. PubMed ID: 11604029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of binary QSAR models derived from LUDI and MOE scoring functions for structure based virtual screening.
    Prathipati P; Saxena AK
    J Chem Inf Model; 2006; 46(1):39-51. PubMed ID: 16426038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.